Cargando…

Antitumor effects of L-BLP25 Antigen-Specific tumor immunotherapy in a novel human MUC1 transgenic lung cancer mouse model

BACKGROUND: L-BLP25 antigen-specific cancer immunotherapeutic agent is currently in phase III clinical trials for non-small cell lung cancer. Using a novel human MUC1 transgenic (hMUC1.Tg) lung cancer mouse model, we evaluated effects of L-BLP25 combined with low-dose cyclophosphamide (CPA) pretreat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wurz, Gregory T, Gutierrez, Audrey M, Greenberg, Brittany E, Vang, Daniel P, Griffey, Stephen M, Kao, Chiao-Jung, Wolf, Michael, DeGregorio, Michael W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3605365/ https://www.ncbi.nlm.nih.gov/pubmed/23496860 http://dx.doi.org/10.1186/1479-5876-11-64

Ejemplares similares

L-BLP25 vaccine plus letrozole for breast cancer: Is translation possible?
por: DeGregorio, Michael, et al.
Publicado: (2012)

Clarifying the pharmacodynamics of tecemotide (L-BLP25)-based combination therapy
por: Kao, Chiao-Jung, et al.
Publicado: (2013)

Safety and efficacy of ospemifene for the treatment of dyspareunia associated with vulvar and vaginal atrophy due to menopause
por: Wurz, Gregory T, et al.
Publicado: (2014)

A comprehensive breath test that confirms recent use of inhaled cannabis within the impairment window
por: DeGregorio, Michael W., et al.
Publicado: (2021)

Ospemifene for the treatment of dyspareunia associated with vulvar and vaginal atrophy: potential benefits in bone and breast
por: Soe, Lin H, et al.
Publicado: (2013)

INSPIRE: A phase III study of the BLP25 liposome vaccine (L-BLP25) in Asian patients with unresectable stage III non-small cell lung cancer
por: Wu, Yi-Long, et al.
Publicado: (2011)

Indeterminacy of cannabis impairment and ∆(9)-tetrahydrocannabinol (∆(9)-THC) levels in blood and breath
por: Wurz, Gregory T., et al.
Publicado: (2022)

Examining impairment and kinetic patterns associated with recent use of hemp-derived Δ(8)-tetrahydrocannabinol: case studies
por: Wurz, Gregory T., et al.
Publicado: (2022)

iBLP: An XGBoost-Based Predictor for Identifying Bioluminescent Proteins
por: Zhang, Dan, et al.
Publicado: (2021)

LICC: L-BLP25 in patients with colorectal carcinoma after curative resection of hepatic metastases--a randomized, placebo-controlled, multicenter, multinational, double-blinded phase II trial
por: Schimanski, Carl Christoph, et al.
Publicado: (2012)

A transgenic mouse model for tumour immunotherapy: induction of an anti-idiotype response to human MUC1
por: Wilkinson, R W, et al.
Publicado: (2000)

Escherichia coli Braun Lipoprotein (BLP) exhibits endotoxemia – like pathology in Swiss albino mice
por: Lakshmikanth, Chikkamenahalli Lakshminarayana, et al.
Publicado: (2016)

Latest developments in MUC1 immunotherapy
por: Taylor-Papadimitriou, Joyce, et al.
Publicado: (2018)

Blp1 protein shows virulence-associated features and elicits protective immunity to Acinetobacter baumannii infection
por: Skerniškytė, Jūratė, et al.
Publicado: (2019)

Distribution of two-component signal transduction systems BlpRH and ComDE across streptococcal species
por: Dhaked, Hemendra Pal Singh, et al.
Publicado: (2022)

Conserved Mutations in the Pneumococcal Bacteriocin Transporter Gene, blpA, Result in a Complex Population Consisting of Producers and Cheaters
por: Son, Matthew R., et al.
Publicado: (2011)

Opposite monosynaptic scaling of BLP–vCA1 inputs governs hopefulness- and helplessness-modulated spatial learning and memory
por: Yang, Ying, et al.
Publicado: (2016)

Advances in MUC1-Mediated Breast Cancer Immunotherapy
por: Li, Zhifeng, et al.
Publicado: (2022)

Local Effects of Regulatory T Cells in MUC1 Transgenic Mice Potentiate Growth of MUC1 Expressing Tumor Cells In Vivo
por: Sugiura, Daisuke, et al.
Publicado: (2012)

Prevention of Inflammation-Driven Colon Carcinogenesis in Human MUC1 Transgenic Mice by Vaccination with MUC1 DNA and Dendritic Cells
por: Murwanti, Retno, et al.
Publicado: (2023)

MUC1 Vaccines, Comprised of Glycosylated or Non-Glycosylated Peptides or Tumor-Derived MUC1, Can Circumvent Immunoediting to Control Tumor Growth in MUC1 Transgenic Mice
por: Lakshminarayanan, Vani, et al.
Publicado: (2016)

Paeoniflorin reduced BLP-induced inflammatory response by inhibiting the NF-κB signal transduction in pathway THP-1 cells
por: Zhang, Qian, et al.
Publicado: (2014)

A unique, inexpensive, and abundantly available adsorbent: composite of synthesized silver nanoparticles (AgNPs) and banana leaves powder (BLP)
por: Darweesh, Mona A., et al.
Publicado: (2022)

Differential Expression of MUC12, MUC16, and MUC20 in Patients with Active and Remission Ulcerative Colitis
por: Yamamoto-Furusho, Jesús K., et al.
Publicado: (2015)

Indomethacin enhances anti-tumor efficacy of a MUC1 peptide vaccine against breast cancer in MUC1 transgenic mice
por: Curry, Jennifer M., et al.
Publicado: (2019)

Specific immunotherapy of MUC1-positive adenocarcinomas with a recombinant vaccinia virus expressing MUC1 and IL-2
por: Bizouarne, N, et al.
Publicado: (2001)

Alteration of ocular surface mucins in MUC5AC-DTA transgenic mice
por: Wang, I-Jong, et al.
Publicado: (2009)

Functional Consequences of Differential O-glycosylation of MUC1, MUC4, and MUC16 (Downstream Effects on Signaling)
por: Hanson, Ryan L., et al.
Publicado: (2016)

Development of breast cancer immunotherapy using MUC1 retargeted T lymphocytes
por: Wilkie, S, et al.
Publicado: (2006)

Development of breast cancer immunotherapy using MUC1-retargeted T lymphocytes
por: Wilkie, S, et al.
Publicado: (2008)

The role of oncogenic MUC1-C in brachyury-induced immunotherapy resistance
por: David, Justin, et al.
Publicado: (2014)

Separation of Plasmacytoid Dendritic Cells from B-Cell-Biased Lymphoid Progenitor (BLP) and Pre-Pro B Cells Using PDCA-1
por: Medina, Kay L., et al.
Publicado: (2013)

Toward Identification of Black Lemma and Pericarp Gene Blp1 in Barley Combining Bulked Segregant Analysis and Specific-Locus Amplified Fragment Sequencing
por: Jia, Qiaojun, et al.
Publicado: (2017)

Identification of new MUC1 epitopes using HLA-transgenic animals: implication for immunomonitoring
por: Scheikl-Gatard, Tanja, et al.
Publicado: (2017)

Metabolic pathways and genes identified by RNA-seq analysis of barley near-isogenic lines differing by allelic state of the Black lemma and pericarp (Blp) gene
por: Glagoleva, Anastasiya Y., et al.
Publicado: (2017)

Legume Consumption Patterns in US Adults: National Health and Nutrition Examination Survey (NHANES) 2011–2014 and Beans, Lentils, Peas (BLP) 2017 Survey
por: Perera, Thushanthi, et al.
Publicado: (2020)

Identification of Novel Genomic Regions for Bacterial Leaf Pustule (BLP) Resistance in Soybean (Glycine max L.) via Integrating Linkage Mapping and Association Analysis
por: Zhao, Fangzhou, et al.
Publicado: (2022)

MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression profiles and clinical significance
por: Betge, Johannes, et al.
Publicado: (2016)

The combination therapy with EpCAM/CD3 BsAb and MUC-1/CD3 BsAb elicited antitumor immunity by T-cell adoptive immunotherapy in lung cancer
por: Wang, Ce, et al.
Publicado: (2021)

Preclinical Studies of Granulysin-Based Anti-MUC1-Tn Immunotoxins as a New Antitumoral Treatment
por: Guerrero-Ochoa, Patricia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6g23kcmk3v95t9vvg9ead871ud